Avicella Capital, established in 2024, is a U.S.-based venture capital firm specializing in healthcare investments. It focuses on identifying and financing innovative, ethically-driven ventures that aim to improve patient outcomes and elevate healthcare standards. The firm concentrates on sectors such as therapeutics, medical devices, diagnostics, and health technology.
Convergence Medical Robotics is a Brisbane-based pre-clinical medical robotics company making arthroscopy better through the invention of the V01 Robot. It solves the complexity of arthroscopy by creating the world's first arthroscopic robot.
Kinoxis Therapeutics
Series B in 2024
Kinoxis Therapeutics is an early-stage biotechnology company based in Australia focused on developing novel therapeutic compounds for substance use disorders and other central nervous system conditions. The company has licensed its lead candidate, which has shown significant anti-addictive and prosocial effects in various animal models, from the University of Sydney. As it advances through pre-clinical testing, Kinoxis aims to address the growing need for effective treatments for opioid withdrawal and other substance-related issues. Their comprehensive medicinal chemistry and screening programs are designed to support the treatment of methamphetamine use disorder and nicotine withdrawal, ultimately contributing to improved outcomes in neurological and psychiatric care.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.